Cowealth Medical China Statistics
Total Valuation
SHA:603122 has a market cap or net worth of CNY 6.19 billion. The enterprise value is 6.17 billion.
| Market Cap | 6.19B |
| Enterprise Value | 6.17B |
Important Dates
The last earnings date was Friday, April 24, 2026.
| Earnings Date | Apr 24, 2026 |
| Ex-Dividend Date | Jul 14, 2025 |
Share Statistics
SHA:603122 has 398.05 million shares outstanding. The number of shares has increased by 18.29% in one year.
| Current Share Class | 398.05M |
| Shares Outstanding | 398.05M |
| Shares Change (YoY) | +18.29% |
| Shares Change (QoQ) | -6.60% |
| Owned by Insiders (%) | 1.73% |
| Owned by Institutions (%) | 1.14% |
| Float | 172.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.43 |
| PB Ratio | 5.92 |
| P/TBV Ratio | 5.97 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -171.76 |
| EV / Sales | 9.40 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -67.82 |
Financial Position
The company has a current ratio of 3.05, with a Debt / Equity ratio of 0.09.
| Current Ratio | 3.05 |
| Quick Ratio | 2.31 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.04 |
| Interest Coverage | -17.16 |
Financial Efficiency
Return on equity (ROE) is -3.23% and return on invested capital (ROIC) is -3.98%.
| Return on Equity (ROE) | -3.23% |
| Return on Assets (ROA) | -1.68% |
| Return on Invested Capital (ROIC) | -3.98% |
| Return on Capital Employed (ROCE) | -3.80% |
| Weighted Average Cost of Capital (WACC) | 4.30% |
| Revenue Per Employee | 3.23M |
| Profits Per Employee | -176,980 |
| Employee Count | 203 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 3.01 |
Taxes
| Income Tax | -6.21M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +138.85% in the last 52 weeks. The beta is 0.01, so SHA:603122's price volatility has been lower than the market average.
| Beta (5Y) | 0.01 |
| 52-Week Price Change | +138.85% |
| 50-Day Moving Average | 16.74 |
| 200-Day Moving Average | 14.21 |
| Relative Strength Index (RSI) | 42.43 |
| Average Volume (20 Days) | 51,906,157 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603122 had revenue of CNY 656.38 million and -35.93 million in losses. Loss per share was -0.08.
| Revenue | 656.38M |
| Gross Profit | 92.25M |
| Operating Income | -39.75M |
| Pretax Income | -42.00M |
| Net Income | -35.93M |
| EBITDA | -32.16M |
| EBIT | -39.75M |
| Loss Per Share | -0.08 |
Balance Sheet
The company has 115.58 million in cash and 94.63 million in debt, with a net cash position of 20.95 million or 0.05 per share.
| Cash & Cash Equivalents | 115.58M |
| Total Debt | 94.63M |
| Net Cash | 20.95M |
| Net Cash Per Share | 0.05 |
| Equity (Book Value) | 1.05B |
| Book Value Per Share | 2.52 |
| Working Capital | 749.61M |
Cash Flow
In the last 12 months, operating cash flow was -77.61 million and capital expenditures -13.38 million, giving a free cash flow of -90.99 million.
| Operating Cash Flow | -77.61M |
| Capital Expenditures | -13.38M |
| Depreciation & Amortization | 7.59M |
| Net Borrowing | 56.31M |
| Free Cash Flow | -90.99M |
| FCF Per Share | -0.23 |
Margins
Gross margin is 14.05%, with operating and profit margins of -6.06% and -5.47%.
| Gross Margin | 14.05% |
| Operating Margin | -6.06% |
| Pretax Margin | -6.40% |
| Profit Margin | -5.47% |
| EBITDA Margin | -4.90% |
| EBIT Margin | -6.06% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 0.84%.
| Dividend Per Share | 0.13 |
| Dividend Yield | 0.84% |
| Dividend Growth (YoY) | 116.67% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -18.29% |
| Shareholder Yield | -17.44% |
| Earnings Yield | -0.58% |
| FCF Yield | -1.47% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |